Skip to main content
Clinical Trials/NCT06361342
NCT06361342
Active, Not Recruiting
N/A

Smartphones Aggravating Anxiety Symptoms: Experimental Study From Southeastern

Mayo Clinic1 site in 1 country100 target enrollmentMarch 8, 2024

Overview

Phase
N/A
Intervention
General decrease in smartphone use
Conditions
Anxiety
Sponsor
Mayo Clinic
Enrollment
100
Locations
1
Primary Endpoint
Change in anxiety
Status
Active, Not Recruiting
Last Updated
3 months ago

Overview

Brief Summary

The goal of this study is to assess if excessive use of smartphone apps of social media can impact a person's mental health. The study is aimed at improving the usage of smartphones which might help improve the mental health of patients. The goal is not to discourage the use of smartphones but instead to utilize smartphones in a way that they do not impact lives.

Registry
clinicaltrials.gov
Start Date
March 8, 2024
End Date
December 1, 2026
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gagandeep Singh

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • For patients aged 18 years or older experiencing mild symptoms of anxiety or depression and who have a GAD-7 score 5 and above.
  • Patient should have smart phone and should be using Facebook, Instagram, Twitter, Tik Tok, and Pinterest social media apps.
  • Patients should have email access.

Exclusion Criteria

  • Any patient who uses a smartphone for tracking glucose for diabetes management, heart rate, or any chronic illness which is being managed through a smartphone app.
  • Any patient who uses more than one personal smartphone
  • Any patient who is a suicide risk as per PHQ-9 score, current recreational drug usage, or alcohol abuse.
  • Any patient who has suicidal ideation as per PHQ-9 assessment before or during the study period will be excluded, (all patients will be monitored for suicidal ideation by PHQ-9 scoring method at day 1, week 6, and week 12, but it is the responsibility of the patient to inform the study team if they have developed any suicidal ideation throughout the study period).
  • Patients with activated POA (Power of Attorney - Healthcare), diagnosis of mental retardation or current disability due to any psychiatric disorder or severe depression with a high risk of suicide should be excluded.
  • Any patient currently undergoing ECT (electroconvulsive therapy) for severe depression.
  • Any patient taking prescribed SSRIs/SNRIs, with a change and not taking them continuously in last 30 days (not a new diagnosis of anxiety). If change they will be excluded.

Arms & Interventions

General decrease in smartphone use.

Subjects will limit their time on smartphone.

Intervention: General decrease in smartphone use

Avoid certain social media apps

Subjects will limit time on smartphone, in particular avoiding use of social media apps on the smartphone which includes Twitter, Facebook, Tik Tok, Instagram, and Pinterest.

Intervention: Avoiding Social Media Apps

Outcomes

Primary Outcomes

Change in anxiety

Time Frame: Day 1, 12 weeks

Measured using the General Anxiety Disorder 7-item (GAD 7) scale to assess severity of generalized anxiety disorder. Scoring is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." Total score for the seven items ranges from 0 to 21 where 0 is no anxiety, 1-4 is minimal anxiety, 5-9 is mild anxiety, 10-14 is moderate anxiety, and 15-21 is severe anxiety.

Secondary Outcomes

  • Change in depression(Day 1, 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials